TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 2 | -1 | -2 | -2 | 80 | 149 | 27 | 42 |
| S | %wins | 100 | 100 | 100 | 0 | 0 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/9/15 19:02 | 3/5/15 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Marshall Paul | CA | O | SVP,Tech | S.d | -1,028 | 14.69 | 4 | -70 | -100 | 0 | D | 26 | 4 | 56 | 87 | 77 | 42 | 26 | 12 | 0 | 0 | -2 | 80 | 149 | 27 |
2/24/12 17:02 | 2/23/12 | AMLN | Amylin Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Marshall Paul | CA | O | SVP,Oper | S | -96 | 17.03 | 33 | -6 | -16 | 30 | D | 4 | 18 | 82 | 75 | 60 | 1 | 2 | 1 | -1 | -4 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |